Behrad Derakhshan, Chief Business Officer at Edgewise Therapeutics, Inc. (EWTX), sold 84,136 shares at $29.03 ($2.4M) on 2024-09-20, disclosed to the SEC on 2024-09-24.
Open-market sale of $2.4M EWTX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.03 | 42,068 | $1.2M | 50.0% |
| 2 | $29.03 | 42,068 | $1.2M | 50.0% |
| Total | $29.03 avg | 84,136 | $2.4M | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $28K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $300K | — | Filing → |
| EWTX | SELL | 2024-05-03 | $32K | — | Filing → |